Granulomas of intestinal tuberculosis and crohn's disease can be differentiated by CD73 cell surface marker expression: A pilot study

Digestive Diseases and Sciences

Volumn 58, Issue 8, 2013, Pages 2301-2307

  Banerjee, Rupa ^a   Balaji, M ^b   Sasikala, M ^b   Anuradha, S ^a   Rao, G V ^a   Reddy, D Nageshwar ^a  

^a ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^b Asian Healthcare Foundation   (India)

Author keywords

CD73 expression; Crohn's disease; Intestinal tuberculosis; Mesenchymal cells

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; THY 1 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFERENCE PAPER; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; INTESTINE TUBERCULOSIS; MALE; MESENCHYME CELL; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

5'-NUCLEOTIDASE; BIOLOGICAL MARKERS; CROHN DISEASE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; GRANULOMA; HUMANS; MESENCHYMAL STROMAL CELLS; PILOT PROJECTS; RETROSPECTIVE STUDIES; TUBERCULOSIS, GASTROINTESTINAL;

EID: 84881479274     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2667-0     Document Type: Conference Paper

References (46)

1. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466.
2. Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182-189.
3. Ouyang Q, Tandon R, Goh KL, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006;21:1772-1782.
4. Makharia GK. Rising incidence and prevalence of Crohn's disease in Asia: is it apparent or real? J Gastroenterol Hepatol. 2006;21:929-931.
5. Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105:642-651.
6. Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol. 2007;26:285-289.
7. Chung KM, Kim HS, Park SY, et al. The changes in incidence of Crohn's disease and intestinal tuberculosis in Korea. Korean J Gastroenterol. 2008;52:351-358.
8. Das K, Ghoshal UC, Dhali GK, et al. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099-1107.
9. Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther. 2007;25:1373-1388.
10. Girardi E, Raviglione MC, Antonucci G, Godfrey-Faussett P, Ippolito G. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS. 2000;14:S47-S56.
11. Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14:741-746.
12. Balamurugan R, Venkataraman S, John KR, Ramakrishna BS. PCR amplification of the IS6110 insertion element of Mycobacterium tuberculosis in fecal samples from patients with intestinal tuberculosis. J Clin Microbiol. 2006;44:1884-1886.
13. Patel N, Amarapurkar D, Agal S, et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004;19:1240-1246.
14. Pulimood AB, Amarapurkar DN, Ghoshal U, et al. Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol. 2011;17:433-443.
15. Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol. 2005;20:688-696.
16. Shah S, Thomas V, Mathan M, et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut. 1992;33:347-351.
17. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterology. 1990;37:18-31.
18. Alvares JF, Devarbhavi H, Makhija P, Rao S, Kottoor R. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy. 2005;37:351-356.
19. Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am J Gastroenterol. 2009;104:1003-1012.
20. Raghuvanshi S, Sharma P, Singh S, Van KL, Das G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci USA. 2010;107:21653-21658.
21. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344-1367.
22. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
23. MacDonald TT, Pettersson S. Bacterial regulation of intestinal immune responses. Inflamm Bowel Dis. 2000;6:116-122.
24. Singh UP, Singh NP, Singh B, et al. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed). 2010;2:993-1008.
25. Kondo T, Nakazawa T, Murata SI, Katoh R. Expression of CD73 and its ecto-5′-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology. 2006;48:612-614.
26. Kirsch R, Pentecost M, Hall PM, et al. Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis. J Clin Pathol. 2006;59:840-844.
27. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 2009;10:943-948.
28. Caprilli R, Lapaquette P, Darfeuille-Michaud A. Eating the enemy in Crohn's disease: an old theory revisited. J Crohns Colitis. 2010;4:377-383.
29. Marks DJ. Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity? Curr Opin Gastroenterol. 2011;27:328-334.
30. Caprilli R, Frieri G. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease. Dig Liver Dis. 2009;41:166-168.
31. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641-650.
32. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15:730-738.
33. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-1822.
34. Di NM, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838-3843.
35. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest energy of activated T cells. Blood. 2005;105:2821-2827.
36. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722-3729.
37. Reinders ME, Fibbe WE, Rabelink TJ. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant. 2010;25:17-24.
38. Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens. 2007;69:1-9.
39. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726-736.
40. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal. 2006;2:351-360.
41. Lennon PF, Taylor CT, Stahl GL, Colgan SP. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med. 1998;188:1433-1443.
42. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001;41:775-787.
43. McCallion K, Harkin DW, Gardiner KR. Role of adenosine in immunomodulation: review of the literature. Crit Care Med. 2004;32:273-277.
44. Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut. 2011;60:788-798.
45. Duijvestein M, van den Brink GR, Hommes DW. Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J Crohns Colitis. 2008;2:99-106.
46. Duijvestein M, Vos AC, Roelofs H, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut. 2010;59:1662-1669.